Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development

2021156 citationsJournal Articlegold Open Access

Authors

Abstract

CD247, FCGR1A, and TRRAP are potential antigens for mRNA vaccine development against cholangiocarcinoma, specifically for patients with IS2 tumors. Therefore, this study provides a theoretical basis for the anti-cholangiocarcinoma mRNA vaccine and defines suitable patients for vaccination.

Topics & Keywords

Cholangiocarcinoma and Gallbladder Cancer Studies Peptidase Inhibition and Analysis RNA modifications and cancer

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Molecular Cancer

Volume 20, Issue 1, pp. 50-50

DOI: 10.1186/s12943-021-01342-6

Field-Weighted Citation Impact: 32.62